TIMM22 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.316000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.714800E-01
Normal-vs-Stage2
4.447200E-01
Normal-vs-Stage3
3.196400E-01
Normal-vs-Stage4
2.979400E-01
Stage1-vs-Stage2
4.147000E-01
Stage1-vs-Stage3
3.922000E-01
Stage1-vs-Stage4
4.765400E-01
Stage2-vs-Stage3
6.320600E-01
Stage2-vs-Stage4
9.088200E-01
Stage3-vs-Stage4
7.743000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.518000E-01
Normal-vs-AfricanAmerican
5.722400E-01
Normal-vs-Asian
1.704980E-01
Caucasian-vs-AfricanAmerican
2.994400E-01
Caucasian-vs-Asian
3.866400E-01
AfricanAmerican-vs-Asian
1.740840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.501800E-01
Normal-vs-Female
7.741800E-01
Male-vs-Female
3.555200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.878600E-01
Normal-vs-Age(41-60Yrs)
9.980400E-01
Normal-vs-Age(61-80Yrs)
3.265800E-01
Normal-vs-Age(81-100Yrs)
3.876400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.129200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.925400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.860400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.570100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.564100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.851600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.642100E-02
Normal-vs-Daily Drinker
4.291400E-01
Normal-vs-Weekly Drinker
7.269400E-01
Normal-vs-Occasional Drinker
8.443000E-01
Normal-vs-Social Drinker
7.661400E-01
Non Drinker-vs-Daily Drinker
4.119800E-01
Non Drinker-vs-Weekly Drinker
1.751370E-01
Non Drinker-vs-Occasional Drinker
7.615800E-02
Non Drinker-vs-Social Drinker
6.972100E-02
Daily Drinker-vs-Weekly Drinker
2.994000E-01
Daily Drinker-vs-Occasional Drinker
3.200000E-01
Daily Drinker-vs-Social Drinker
3.516200E-01
Weekly Drinker-vs-Occasional Drinker
5.990200E-01
Weekly Drinker-vs-Social Drinker
5.604200E-01
Occasional Drinker-vs-Social Drinker
9.282000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.826400E-01
Normal-vs-Grade 2
6.178800E-01
Normal-vs-Grade 3
6.104600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.514440E-02
Grade 1-vs-Grade 3
7.516600E-03
Grade 1-vs-Grade 4
6.826400E-01
Grade 2-vs-Grade 3
3.796600E-01
Grade 2-vs-Grade 4
6.178800E-01
Grade 3-vs-Grade 4
6.104600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.499600E-01
Normal-vs-NonDiabetic
7.635200E-01
Diabetic-vs-NonDiabetic
7.792100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.594300E-02
Normal-vs-NoPancreatitis
6.710600E-01
Pancreatitis-vs-NoPancreatitis
1.282610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.765800E-01
Normal-vs-N1
5.115000E-01
N0-vs-N1
2.027000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.344600E-03
Normal-vs-TP53-NonMutant
7.913200E-01
TP53-Mutant-vs-TP53-NonMutant
2.776300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
